Direkt zum Inhalt
Merck

Fortfahren mit

E2661

Estropipat

≥98% (HPLC), powder

Synonym(e):

Estropipat, 3-(Sulfooxy)-estra-1,3,5(10)-trien-17-on : Piperazin (1:1), Estronsulfat Piperazinsalz

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
PackungsgrößeSKUVerfügbarkeitPreis

Über diesen Artikel

Empirische Formel (Hill-System):
C18H22O5S·C4H10N2
CAS-Nummer:
Molekulargewicht:
436.56
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
51111800
EC Number:
230-696-3
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


Quality Level

assay

≥98% (HPLC)

form

powder

optical activity

[α]/D 100 to 120°, c = 1 in DMSO

color

white to tan

solubility

DMSO: ≥24 mg/mL

originator

Johnson & Johnson

storage temp.

2-8°C

SMILES string

C1CNCCN1.C[C@]23CC[C@H]4[C@@H](CCc5cc(OS(O)(=O)=O)ccc45)[C@@H]2CCC3=O

InChI

1S/C18H22O5S.C4H10N2/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;1-2-6-4-3-5-1/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22);5-6H,1-4H2/t14-,15-,16+,18+;/m1./s1

InChI key

HZEQBCVBILBTEP-ZFINNJDLSA-N

Gene Information

human ... ESR1(2099)

Biochem/physiol Actions

Estropipate is the piperazine salt of the estrogen receptor agonist estrone-3-sulfate and a potent, specific inhibitor of the organic anion transporting polypeptide 1B1 (OATP1B1, IC50 = 60 nM).
Estropipate is the piperazine salt of the estrogen receptor agonist estrone-3-sulfate and a potent, specific inhibitor of the organic anion transporting polypeptide 1B1.

Features and Benefits

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound is featured on the Nuclear Receptors (Steroids) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
1255500BP616SML1405
Estropipate United States Pharmacopeia (USP) Reference Standard

USP

1255500

Estropipate

Estropipate British Pharmacopoeia (BP) Reference Standard

BP616

Estropipate

assay

≥98% (HPLC)

assay

-

assay

-

assay

≥98% (HPLC)

form

powder

form

-

form

solid

form

powder

Quality Level

100

Quality Level

-

Quality Level

-

Quality Level

100

storage temp.

2-8°C

storage temp.

-

storage temp.

2-8°C

storage temp.

−20°C

solubility

DMSO: ≥24 mg/mL

solubility

-

solubility

-

solubility

DMSO: 20 mg/mL, clear

originator

Johnson & Johnson

originator

-

originator

-

originator

-


Still not finding the right product?

Explore all of our products under Estropipat


pictograms

Health hazardExclamation mark

signalword

Danger

hcodes

Hazard Classifications

Acute Tox. 4 Oral - Carc. 1A

Lagerklasse

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen


Artikel

We offers many products related to Nuclear Receptors (Steroids) for your research needs.

Discover Bioactive Small Molecules for ADME/Tox


Juliana Félix-Silva et al.
PloS one, 9(8), e104952-e104952 (2014-08-16)
Snakebites are a serious public health problem due their high morbi-mortality. The main available specific treatment is the antivenom serum therapy, which has some disadvantages, such as poor neutralization of local effects, risk of immunological reactions, high cost and difficult
Andrea Doni et al.
The Journal of experimental medicine, 212(6), 905-925 (2015-05-13)
Pentraxin 3 (PTX3) is a fluid-phase pattern recognition molecule and a key component of the humoral arm of innate immunity. In four different models of tissue damage in mice, PTX3 deficiency was associated with increased fibrin deposition and persistence, and



Global Trade Item Number

SKUGTIN
E2661-5MG04061833602881
E2661-25MG04061832867151

Questions

Reviews

No rating value

Active Filters